US 11813278
Highly active compounds against COVID-19
granted A61KA61K31/706A61K31/7064
Quick answer
US patent 11813278 (Highly active compounds against COVID-19) held by Atea Pharmaceuticals, Inc. expires Mon Nov 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Atea Pharmaceuticals, Inc.
- Grant date
- Tue Nov 14 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 37
- CPC classes
- A61K, A61K31/706, A61K31/7064, A61K31/7076, A61K9/0019